Heartflow Inc (HTFL) reported disappointing financial results for the third quarter of fiscal 2025. The company posted an earnings per share (EPS) of $-0.27, falling short of Wall Street's consensus estimate of $-0.22 by $0.05. Revenue remained at $0.0B, aligning with expectations but indicating a lack of growth.
The company, headquartered in Mountain View, California, specializes in diagnosing coronary artery diseases. Its innovative HeartFlow Platform utilizes AI and advanced computational fluid dynamics to create personalized three-dimensional models of patients' hearts based on a single coronary computed tomography angiography (CCTA). The platform includes features like Roadmap Analysis, FFRCT Analysis, and Plaque Analysis, which assist physicians in delivering precision care to patients with coronary artery disease (CAD).
Management will host an earnings conference call to discuss these results and provide further commentary on business performance. This update provides insight into Heartflow Inc's recent operational challenges and financial health, as missing analyst expectations could reflect broader market conditions.
Investors are encouraged to review the full earnings release and listen to management's commentary for complete context on the quarter's performance and future outlook.